Biotechnology Industry Organization (BIO), Washington, DC 20024, USA.
Science. 2011 Sep 2;333(6047):1254-6. doi: 10.1126/science.1211066.
In our view, synthetic biology is an extension of the continuum of genetic science that has been used safely for more than 40 years by the biotechnology industry in the development of commercial products. Examples of synthetic biology use by biotechnology companies illustrate the potential to substantially reduce research and development time and to increase speed to market. Improvements in the speed and cost of DNA synthesis are enabling scientists to design modified bacterial chromosomes that can be used in the production of renewable chemicals, biofuels, bioproducts, renewable specialty chemicals, pharmaceutical intermediates, fine chemicals, food ingredients, and health care products. Regulatory options should support innovation and commercial development of new products while protecting the public from potential harms.
在我们看来，合成生物学是遗传科学连续体的延伸，生物技术行业在开发商业产品方面已经安全地使用了超过 40 年。生物技术公司使用合成生物学的例子说明了大幅缩短研发时间和加快推向市场速度的潜力。DNA 合成速度和成本的提高使科学家能够设计可用于生产可再生化学品、生物燃料、生物制品、可再生特种化学品、制药中间体、精细化学品、食品成分和保健品的改良细菌染色体。监管选择应支持新产品的创新和商业开发，同时保护公众免受潜在危害。
